Richard Morris - 17 Jun 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Chief Financial Officer
Signature
/s/ Richard Morris
Issuer symbol
CARM
Transactions as of
17 Jun 2024
Net transactions value
$0
Form type
4
Filing time
18 Jun 2024, 19:08:16 UTC
Previous filing
02 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +85,000 $0.000000 85,000 17 Jun 2024 Common Stock 85,000 $1.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over two years, with 50% of the shares vesting on June 17, 2025 and the remaining 50% of the shares vesting on June 17, 2026, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.